---
title: "BrightSpring Health Services - Unit | 8-K: FY2025 Q1 Revenue: USD 2.878 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238558530.md"
datetime: "2025-05-02T10:06:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238558530.md)
  - [en](https://longbridge.com/en/news/238558530.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238558530.md)
generator: "portal-rs"
---

# BrightSpring Health Services - Unit | 8-K: FY2025 Q1 Revenue: USD 2.878 B

Revenue: As of FY2025 Q1, the actual value is USD 2.878 B.

EPS: As of FY2025 Q1, the actual value is USD 0.14.

EBIT: As of FY2025 Q1, the actual value is USD 91.57 M.

### Segment Revenue

-   **Pharmacy Solutions Revenue**: $2,532 million, up 28% from $1,977 million in the first quarter of 2024.
-   **Provider Services Revenue**: $346 million, up 12% from $309 million in the first quarter of 2024.

### Operational Metrics

-   **Net Income from Continuing Operations**: $9.2 million, compared to a Net Loss of $56.0 million in the first quarter of 2024.
-   **Gross Profit**: $338 million, up 15.7% from $292 million in the first quarter of 2024.
-   **Operating Income**: $50.7 million, compared to an Operating Loss of - $15.3 million in the first quarter of 2024.

### Cash Flow

-   **Net Cash Provided by Operating Activities**: $101.6 million, compared to - $78.9 million in the first quarter of 2024.

### Unique Metrics

-   **Adjusted EBITDA**: $131 million, up 28.2% from $102 million in the first quarter of 2024.

### Outlook / Guidance

BrightSpring Health Services has increased its full-year 2025 guidance, projecting net revenue between $12,000 million and $12,500 million, and Adjusted EBITDA between $570 million and $585 million. The Pharmacy Segment Revenue is expected to grow between 20.5% and 25.7%, while the Provider Segment Revenue is anticipated to increase between 10.0% and 13.8%.

### Related Stocks

- [BTSGU.US](https://longbridge.com/en/quote/BTSGU.US.md)

## Related News & Research

- [3,759 Shares in Ferrari N.V. $RACE Acquired by X Square Capital LLC](https://longbridge.com/en/news/296700358.md)
- [Powerful Growth, Multiple Endorsements Bode Well for Oracle Stock](https://longbridge.com/en/news/296686709.md)
- [Korea Investment CORP Increases Stock Position in L3Harris Technologies Inc $LHX](https://longbridge.com/en/news/296698330.md)
- [Johnson & Johnson $JNJ Position Reduced by Oppenheimer Asset Management Inc.](https://longbridge.com/en/news/296697035.md)
- [Danske Bank A S Invests $252.05 Million in Bank of America Corporation $BAC](https://longbridge.com/en/news/296695181.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**